DE60235545D1 - Verfahren zur behandlung von nagelpilz und anderen mikrobiellen und mykotischen erkrankungen und dafür geeignete zusammensetzungen - Google Patents

Verfahren zur behandlung von nagelpilz und anderen mikrobiellen und mykotischen erkrankungen und dafür geeignete zusammensetzungen

Info

Publication number
DE60235545D1
DE60235545D1 DE60235545T DE60235545T DE60235545D1 DE 60235545 D1 DE60235545 D1 DE 60235545D1 DE 60235545 T DE60235545 T DE 60235545T DE 60235545 T DE60235545 T DE 60235545T DE 60235545 D1 DE60235545 D1 DE 60235545D1
Authority
DE
Germany
Prior art keywords
nail
treatment
microbial
compositions suitable
suitable therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235545T
Other languages
German (de)
English (en)
Inventor
Mark H Bogart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60235545D1 publication Critical patent/DE60235545D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60235545T 2001-06-04 2002-05-03 Verfahren zur behandlung von nagelpilz und anderen mikrobiellen und mykotischen erkrankungen und dafür geeignete zusammensetzungen Expired - Lifetime DE60235545D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/873,773 US6664292B2 (en) 2001-06-04 2001-06-04 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
PCT/US2002/014007 WO2002098402A1 (en) 2001-06-04 2002-05-03 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor

Publications (1)

Publication Number Publication Date
DE60235545D1 true DE60235545D1 (de) 2010-04-15

Family

ID=25362282

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235545T Expired - Lifetime DE60235545D1 (de) 2001-06-04 2002-05-03 Verfahren zur behandlung von nagelpilz und anderen mikrobiellen und mykotischen erkrankungen und dafür geeignete zusammensetzungen

Country Status (8)

Country Link
US (1) US6664292B2 (enExample)
EP (1) EP1401421B1 (enExample)
JP (1) JP2004532882A (enExample)
AT (1) ATE459349T1 (enExample)
CA (1) CA2449312C (enExample)
DE (1) DE60235545D1 (enExample)
ES (1) ES2343352T3 (enExample)
WO (1) WO2002098402A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030235607A1 (en) * 1998-02-13 2003-12-25 Buck Carol J. Compositions and methods for inhibiting fungal growth and transference
AU2002364893A1 (en) * 2001-10-22 2003-06-17 University Of Mississippi Delivery of medicaments to the nail
US20070014743A1 (en) * 2002-09-27 2007-01-18 Birnbaum Jay E Subunguicide, and method for treating onychomycosis
US8404751B2 (en) * 2002-09-27 2013-03-26 Hallux, Inc. Subunguicide, and method for treating onychomycosis
US7135194B2 (en) * 2002-09-27 2006-11-14 Birnbaum Jay E Subunguicide, and method for treating onychomycosis
FR2863168A1 (fr) * 2003-12-04 2005-06-10 Centre Nat Rech Scient Utilisation d'inducteurs de la voie de degradation de la gamma-butyrolactone pour inactiver le signal n-acy homoserine lactone.
US7338967B2 (en) * 2004-09-10 2008-03-04 Syngenta Limited Substituted isoxazoles as fungicides
GB0511499D0 (en) * 2005-06-06 2005-07-13 Medpharm Ltd Topical ungual formulations
JP5237111B2 (ja) 2005-12-19 2013-07-17 シンジェンタ リミテッド 殺菌剤としての置換型芳香族複素環式化合物
US20070243222A1 (en) * 2006-02-03 2007-10-18 Carl Lawyer Fungicidal formulation and method of use
US20090215888A1 (en) * 2006-03-02 2009-08-27 Singh Jagat Topical nail formulation
US20090192125A1 (en) * 2007-02-08 2009-07-30 Dermworx Incorporated Local anti-infective agent for treatment of nail fungal infections
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US20100145373A1 (en) * 2008-12-05 2010-06-10 Ruth Alon Nail drill
KR20120015319A (ko) * 2009-05-15 2012-02-21 바이오셉타 코포레이션 피부 및 손발톱의 진균 감염의 국소적 치료에 적절한 조성물
US20100292333A1 (en) * 2009-05-15 2010-11-18 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
US8979820B2 (en) 2009-10-09 2015-03-17 Cynthia S. Bailey Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes
US20110083692A1 (en) * 2009-10-09 2011-04-14 Cynthia Bailey Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of highly concentrated or supersaturated boric acid
NL2003786C2 (en) 2009-11-11 2010-07-30 Medner B V COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
BE1018742A3 (nl) * 2010-09-02 2011-07-05 Oystershell Nv Samenstelling voor de behandeling van nagelschimmelziektes en gebruik hiervan.
ES2561814T3 (es) * 2010-09-17 2016-03-01 Abbell Ab Tratamiento de infecciones micóticas
USD728161S1 (en) 2012-08-08 2015-04-28 Young Nails Inc. Nail care device
AU2014241396A1 (en) 2013-03-14 2015-09-17 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
CN105683184B (zh) 2013-10-03 2019-05-10 道尔医药科学公司 稳定的艾菲康唑组合物
CA2931144C (en) 2013-11-22 2020-02-04 Dow Pharmaceutical Sciences, Inc. Anti-infective methods, compositions, and devices

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2970032A (en) * 1957-05-27 1961-01-31 Otto C Jekel Stable solutions of compounds of tannins with boric acid
US4180058A (en) * 1978-08-15 1979-12-25 Jacob Brem Method of treating pathological conditions of the nail
US4975217A (en) * 1981-07-20 1990-12-04 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
DE3622089A1 (de) * 1986-07-02 1988-01-07 Krueger Gmbh & Co Kg Viruzides mittel mit breitbandwirkung
US5547988B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Alleviating signs of dermatological aging with glycolic acid lactic acid or citric acid
US5641475A (en) * 1987-05-15 1997-06-24 Tristrata, Inc. Antiodor, antimicrobial and preservative compositions and methods of using same
US4986963A (en) * 1989-01-24 1991-01-22 Corcoran Richard A Method of disinfecting contact lenses with peracetic acid
CA1337329C (en) * 1989-01-31 1995-10-17 Paul L. Simmons Biodegradable disinfectant
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
WO1993011735A1 (en) 1991-12-18 1993-06-24 Advanced Oxygen Technologies, Inc. Treatment of fungal infections
DE19518262A1 (de) * 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
US5916545A (en) 1993-07-28 1999-06-29 Pfizer Inc. Antifungal nail solution
US5391367A (en) 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
US6066670A (en) * 1994-06-08 2000-05-23 Brown; Raymond K. Therapeutic compositions and methods of use
US5519059A (en) * 1994-08-17 1996-05-21 Sawaya; Assad S. Antifungal formulation
US5652256A (en) 1995-06-06 1997-07-29 Knowles; W. Roy Topical composition for fungal treatment
US5613538A (en) * 1995-10-18 1997-03-25 Denis Comact Inc. Knife holder for timber shaping and chip producing head
US5968986A (en) * 1997-12-18 1999-10-19 Woodward Laboratories, Inc. Antimicrobial nail coating composition
US5853767A (en) 1997-01-02 1998-12-29 Melman; Steven A. Compositions for treating fungal, parasitic and/or bacterial infections, especially infections of organs such as the skin and vagina
US5993790A (en) 1997-08-04 1999-11-30 Pedinol Pharmacal Inc. Nail evulsion compositions and method for evulsing nails and treating nail and nail bed infections
US6231840B1 (en) 1998-02-13 2001-05-15 Carol J. Buck Compositions and methods for the topical treatment of nail fungi conditions
ITVR980033A1 (it) * 1998-04-30 1999-10-30 Farmec Di Tabasso Renato & C S Procedimento per l'ottenimento estemporaneo di un disinfettante a base di acido peracetico.
US6632443B2 (en) * 2000-02-23 2003-10-14 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
WO2001012173A1 (en) * 1999-08-13 2001-02-22 Effcon Laboratories, Inc. Low concentration pest treatment composition and method

Also Published As

Publication number Publication date
JP2004532882A (ja) 2004-10-28
US20020183387A1 (en) 2002-12-05
WO2002098402A1 (en) 2002-12-12
EP1401421B1 (en) 2010-03-03
EP1401421A1 (en) 2004-03-31
CA2449312A1 (en) 2002-12-12
ES2343352T3 (es) 2010-07-29
CA2449312C (en) 2011-11-22
EP1401421A4 (en) 2004-09-15
ATE459349T1 (de) 2010-03-15
US6664292B2 (en) 2003-12-16

Similar Documents

Publication Publication Date Title
DE60235545D1 (de) Verfahren zur behandlung von nagelpilz und anderen mikrobiellen und mykotischen erkrankungen und dafür geeignete zusammensetzungen
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
AU2002361878A1 (en) Method of improving wound healing
DE60330161D1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
ATE302017T1 (de) Zusammensetzung zur behandlung von durch arterielle irrigationsdefekt gewebeschäden
ATE515253T1 (de) Zusammensetzungen auf basis von etyllinoleat und triethylcitrat zur behandlung von seborrhöe und akne
DE60310400D1 (de) Botulinustoxine zur behandlung von priapismus
DE60026279D1 (de) Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i
DE60231050D1 (de) Verwendung von Totarol zur Behandlung von Pruritus
DE602004012578D1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
DE60237039D1 (de) Verfahren zur behandlung von rosacea und telangiectasia
ATE430572T1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
WO2006003492A3 (en) Compositions and methods for treating pathological infections
DE60218227D1 (de) Topisches dapson zur behandlung von akne
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
EP4173494A4 (en) Composition for preventing, ameliorating, or treating diseases caused by nitration of tyrosine in protein, containing tyrosine as active ingredient
ATE445644T1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
DE60021732D1 (de) Pilzwachstumsmedium zur behandlung von pilzinfektionen
ATE453386T1 (de) Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition